![DePinho's Nixing of Tenure Renewals May Bring Censure to MD Anderson](https://cdn.cancerletter.com/media/2024/01/07010934/40-17-smith-reaserach-building.jpg)
![DePinho's Nixing of Tenure Renewals May Bring Censure to MD Anderson](https://cdn.cancerletter.com/media/2024/01/07010934/40-17-smith-reaserach-building.jpg)
Cover Story
By Matthew Bin Han Ong
A year before Kapil Mehta's tenure term expired last August, the 11-member Promotions and Tenure Committee at MD Anderson Cancer Center had unanimously recommended renewal.
In Brief
Trending Stories
- How a Georgetown med school student found her calling in surgery, law, and health equity
- Jeffrey S. Weber, pioneering immunologist and melanoma expert at NYU, dies at 72
- Laurie Glimcher to step down as Dana-Farber president and CEO, Benjamin Levine Ebert named successor
- Lei Zheng got his PhD in San Antonio; now he returns as cancer center director at Mays
- As NCI’s appropriations stay flat, Rathmell keeps the FY26 bypass budget steady at just under $11.5B
Rathmell: “We understand that there are real economic constraints facing our country and the world. But our gap just can’t keep widening.” - UChicago Cancer Luminaries Podcast: Todd Golub discusses mentorship, interdisciplinary research